Day: October 11, 2021

Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company’s presentation will be available on Stryker’s website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site. To listen to the meeting via phone dial (844) 200-6205 (domestic) or (929) 526-1599 (international) and enter access code 695616. A recording of the meeting will also be available from 8:30 p.m., Eastern Time, on Thursday, November 18, 2021, until 11:59 p.m., Eastern Time, on Thursday, November 25, 2021. To hear this recording, you may dial (866) 813-9403 (domestic) or (929) 458-6194 (international) and enter access code 413779. Stryker...

Available in AEC-Q101 Qualified Versions, 40 V and 100 V Devices Save Space and Improve Thermal Performance Over Diodes in Traditional SOD/T Packages MALVERN, Pa., Oct. 11, 2021 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced new surface-mount small signal diodes in the ultra compact DFN1006-2A plastic package with wettable flanks. Designed to save space and improve thermal performance in automotive and industrial applications, the 40 V BAS40L Schottky and 100 V BAS16L switching diodes are each available in AEC-Q101 qualified versions. Measuring only 1 mm by 0.6 mm by 0.45 mm, the diodes released today occupy 90 % less board space than devices in traditional SOD/T packages while offering a 50 % lower profile and better power dissipation. For protection again excessive voltage, such as electrostatic...

Switchcraft’s immersive world and fully-realized characters take Match 3 gaming to the next level The casual game takes players on an interactive journey through the eyes of a female protagonist exploring her magical powers The launch of Switchcraft is a further milestone for Playtika in 2021, following the company’s IPO in JanuaryHERZLIYA, Israel, Oct. 11, 2021 (GLOBE NEWSWIRE) — Playtika Holding corp. (NASDAQ: PLTK) today announced the global launch of Switchcraft, developed by its Berlin-based game studio Wooga GmbH. Switchcraft is a casual game that marries interactive, narrative storylines with Match 3 mechanics, combining the best of puzzle-centered gameplay with an immersive and gripping narrative. The game’s protagonist is a young woman — Bailey Ward — living in a small town in Massachusetts on the...

Bombardier’s presence at NBAA-BACE offers exceptional experience for visitors In addition to its industry-leading aircraft on display, Bombardier showcases innovation in super mid-size segment with stunning interior mock-up of new Challenger 3500 business jet Customer Service offerings gain steam amid worldwide expansion, including significant growth in the U.S.LAS VEGAS, Oct. 11, 2021 (GLOBE NEWSWIRE) — Kicking off its first in-person attendance at a major airshow in two years, Bombardier is thrilled to present the stunning interior mock-up of the Challenger 3500 business jet, and honored to announce that the launch customer for this new aircraft is Les Goldberg, Chairman and CEO of Entertainment Technology Partners. Mr. Goldberg, a long-time Bombardier customer, will join the festivities as Bombardier celebrates its presence...

SYDNEY, Oct. 11, 2021 (GLOBE NEWSWIRE) — Medlab Clinical LTD (ASX:MDC) is pleased to announce the Orotate patent, specifically to addressing depression in United States of America has been granted. The United States Patent and Trademark Office (USPTO) has applied a Patent term to 28 MAY 2037 with a US patent number 11,135,181. Previously Medlab announced [5 Jul 2021] final trial readouts for its phase 2 Depression trials.Orotate use as a drug substance was key to the investigative product “NRGBiotic™”. The company has previously signalled that NRGBiotic™ will undertake improvements to simplify the formulation and ultimately that will make this treatment more affordable to patients and prescribers. The Depression and the Orotate patent covers the following territories:• United States • Europe • Hong Kong• Australia • New Zealand    • Canada • Singapore    Dr...

HASBROUCK HEIGHTS, N.J., Oct. 11, 2021 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to report today a one-month update to shareholders as a follow-up to the September communication. The Company reinforces that its completion tasks for the important Fexapotide filing have advanced as anticipated and that substantial progress has ensued. Company CEO Paul Averback stated, “We are happy to follow-up today and tell our shareholders that the main delayed vendor documentation that was incomplete has been accomplished. We are now certain to have our full documentation for those materials completed. There remain some standard quality control steps that are typically involved. Our next follow-up is expected to provide a more exact forward date for filing as soon as it is in our hands...

COMPANY ANNOUNCEMENT                                                                                                                     No. 107/2021 Tvis, 11 October 2021 Correction There are no corrections to the English version.Transactions in connection with share buy-back programme As mentioned in announcement no. 77/2021, TCM Group A/S (”TCM Group” or ”the Company”) has initiated a share buy-back programme which will run from 26 April 2021 until 11 March 2022. During this period, the Company will buy own shares for up to a maximum of DKK 100 million under the programme. The share buyback has been set up and structured in accordance with the safe harbour rules in art. 5 of the Market Abuse Regulation and the European Commission Regulation 1052/2016 of 8 March 2016. The following transactions have been executed during the period...